FDA Brief

Warning letters Drugs

FDA warning letter to

Supercore Products Group, Inc.

High riskIssued Sep 26, 2024Posted Oct 1, 2024Center for Drug Evaluation and Research (CDER)

FDA warns Supercore that Hard Steel and Gold Hard Steel Plus are unapproved, mislabeled drugs with hidden sildenafil; Hard Steel also has acetaminophen.

What happened

FDA reviewed the company's website from May to September 2024, where orders are taken for Hard Steel and Gold Hard Steel Plus, and FDA obtained a sample and labeling. Laboratory analysis found undeclared sildenafil and acetaminophen in Hard Steel and undeclared sildenafil in Gold Hard Steel Plus. The letter also says the website offers Pink Pussycat and HoneyGizer variations; previous FDA analyses of similarly named products found undeclared sildenafil, though FDA had not sampled these variations from the company's inventory.

What FDA found

  1. The products are drugs that require FDA approval, and they were sold without it.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  2. Their labels do not disclose sildenafil or acetaminophen, so the labeling is false or misleading.

    FD&C Act section 502(a), 21 U.S.C. 352(a)
  3. Their labeling does not give adequate directions for safe use by a layperson.

    FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1)
  4. Their labeling lacks adequate warnings about the undeclared drug ingredients.

    FD&C Act section 502(f)(2), 21 U.S.C. 352(f)(2)
  5. They are marketed as dietary supplements even though sildenafil was approved as a drug before being marketed as a supplement or food.

    FD&C Act section 201(ff)(3)(B)(i), 21 U.S.C. 321(ff)(3)(B)(i)
  6. The products are sold across state lines while misbranded.

    FD&C Act section 301(a), 21 U.S.C. 331(a)

What FDA wants

FDA asks the company to notify it in writing within 15 working days of the specific steps taken to correct violations, prevent recurrence, and include related documentation. If the company believes there is no violation, it must explain why with supporting information; if correction cannot be completed in 15 working days, it must state the reason and completion time.

Who should pay attention

  • retailers and online marketplaces selling male enhancement supplements
  • brands and distributors that buy supplement products from Supercore
  • consumers who take nitrate medicines or acetaminophen-containing products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  2. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk